Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-23-010776
Filing Date
2023-06-02
Accepted
2023-06-02 17:19:58
Documents
3
Period of Report
2023-07-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20230720xpre14a.htm PRE 14A 858658
2 GRAPHIC tmb-20230720xpre14a_bg001.jpg GRAPHIC 174987
3 GRAPHIC tmb-20230720xpre14a_bg002.jpg GRAPHIC 213911
  Complete submission text file 0001558370-23-010776.txt   1395636
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35182 | Film No.: 23990186
SIC: 2834 Pharmaceutical Preparations